Your browser doesn't support javascript.
loading
A Patient Charter for Chronic Obstructive Pulmonary Disease.
Hurst, John R; Winders, Tonya; Worth, Heinrich; Bhutani, Mohit; Gruffydd-Jones, Kevin; Stolz, Daiana; Dransfield, Mark T.
Afiliação
  • Hurst JR; UCL Respiratory, University College London, London, UK. j.hurst@ucl.ac.uk.
  • Winders T; Allergy and Asthma Network, Global Allergy and Airways Patient Platform, Vienna, VA, USA.
  • Worth H; Vice-Chairman of the German Airways League, Specialists Forum, Furth, Germany.
  • Bhutani M; Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
  • Gruffydd-Jones K; Box Surgery, Box, Corsham, Wiltshire, UK.
  • Stolz D; Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, Switzerland.
  • Dransfield MT; Division of Pulmonary, Allergy, and Critical Care Medicine, Lung Health Center, The University of Alabama at Birmingham, Birmingham, AL, USA.
Adv Ther ; 38(1): 11-23, 2021 01.
Article em En | MEDLINE | ID: mdl-33245531
ABSTRACT
Chronic obstructive pulmonary disease (COPD) has a profound impact on people living with the disease and has a high global economic and social burden. Often, people with COPD are undiagnosed, while those diagnosed are undertreated and undereducated on different aspects of COPD care. Although there are many published evidence-based treatment guidelines from different expert groups and societies, they are frequently not adhered to, which results in significant gaps in care. In particular, 'flare-ups' (known as exacerbations of COPD), which accelerate disease progression, are often under-reported, despite guidelines recommending an escalation of maintenance treatment to prevent subsequent flare-ups. Management of COPD should be proactive to prevent worsening of symptoms and to reduce the risk of future flare-ups and premature death, rather than a secondary reaction to a worsening health status. Key to this is patient access to accurate diagnosis, effective treatment and specialist care, which can vary widely due to socioeconomic differences, geographical locations and poor guideline implementation. In addition, the stigma associated with COPD can act as a barrier, which can result in people being reluctant to access treatment or clinicians being nihilistic. As global patient advocates, we have co-developed this patient charter to set a standard of care that people living with COPD should expect, raising awareness and understanding of the causes and consequences of COPD as well as the potential to improve patient care. Patients with COPD should be empowered to live the highest quality of life possible with the least number of flare-ups. We set out six principles in line with current COPD guideline recommendations, that should be implemented by governments, healthcare providers, policymakers, lung health industry partners and patients/caregivers to drive meaningful change in COPD care.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Doença Pulmonar Obstrutiva Crônica Tipo de estudo: Guideline Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Adv Ther Assunto da revista: TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Doença Pulmonar Obstrutiva Crônica Tipo de estudo: Guideline Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Adv Ther Assunto da revista: TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido